Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
0.00%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 27 February 2024 6:17 am  |  Updated:  Tuesday 27 February 2024 10:13 am

Meet the women building a new way to deal with cancer

By: Jennifer Sieg

SME Correspondent

Add as a preferred source on Google
Perci Health co-founders Morgan Fitzsimons and Kelly McCabe realised there was a gap that needed filling within the healthcare sector.
Perci Health co-founders Morgan Fitzsimons and Kelly McCabe realised there was a gap that needed filling within the healthcare sector.

The latest in our Ambition A.M. series sees Jennifer Sieg speak to the women behind a virtual cancer support centre.

A pot of coffee wasn’t the only thing brewing in the background the day Kelly McCabe and Morgan Fitzsimons sat down to chat at their local cafe. “There’s a thing…” Fitzsimons recalled hearing her colleague say before being presented with an out-of-the-blue business opportunity.

As one ‘thing’ led to another, the now-co-founders of Perci Health – a virtual cancer support clinic – quickly realised the difference in their skill sets would soon become their formula for success. Especially when the mission is to leverage technology in a way that easily connects patients with human practitioners.

The two agreed the past three years have been worthwhile – thanks to the resilience that comes with “throwing spaghetti at the wall” – but launching a paid-for healthcare platform in Britain wasn’t an easy task.

The formula for success

Disruptive innovation often comes when two entrepreneurs are committed to making a change. At least, that’s what happened when Fitzsimons and McCabe realised there was a gap that needed filling within the healthcare sector.

McCabe, who spent over a decade working in the NHS and private sector, spotted the need for digital innovation when she noticed a growing number of cancer ‘survivors’ – a word Fitzsimons admitted not everyone likes – still seeking guidance after their treatments ended.

But, like any new business venture, the idea to provide accessible healthcare options to these patients could only go so far without a strong plan in motion.

McCabe knew she needed Fitzsimons’ digital-led background to make it work. “Leaning too heavily into clinical without thinking about the member experience, or building a great product but without the clinical know-how can all be disastrous,” McCabe said.

I believe we’ve got the perfect balance, further complemented now by our growing team.

Kelly McCabe

Fitzsimons agreed as she said the two often laugh over how she has personally “gotten really good at getting people to buy stuff they don’t need” throughout her previous digital marketing roles within online retailers, including a full three years at Asos.

Now using what she called her “evil skills for good,” Fitzsimons said much of what Perci Health had as a barrier from the start was the need to educate others on what they were trying to achieve – and in this case, what patients needed.

“There’s an assumption that this is being taken care of somewhere, everyone assumes that someone else is doing it,” Fitzsimons said.

Read more

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

“So you talk to private healthcare, and they’re like ‘oh, don’t the NHS do it?’ and then you talk to the NHS and they’re like ‘don’t charities do it?’ and then you talk to charities, and they’re like ‘don’t GPs do it?’” she continued.

Fitzsimons considered much of this back-and-forth to be like a game of tennis, but it wasn’t until they spoke with the patients directly that they realised they were the first to offer this post-treatment guidance.

Despite inevitable challenges on the horizon, the two worked their way through to “regroup, regather and pivot,” Fitzsimons said while hand-gesturing a bumpy ride.

Leveraging technology

With little hesitation, Fitzsimons said the biggest challenge to date was setting out to build a paid-for healthcare system in a country where healthcare access is available for free.

“Who is going to pay for this is the hardest thing,” she added. “Obviously we found some routes to market, and I guess that’s my bread and butter, but healthcare is a specific challenge.”

The ultimate goal, Fitzsimons said, is to give everyone affordable access to the healthcare they need – hopefully through a future partnership with the NHS – but to do that they need to get their feet off the ground, first.

“Working out who is willing to pay for this care so that the person with cancer doesn’t have to and so we can reach the scale we want to has been challenging,” McCabe added.

So far, Perci Health has partnered with large insurers – including Healix Health and L&G – to allow each insurer’s patients free access to their platform’s support.

These continued achievements and partnerships throughout the hardships help make way for Perci Health’s “longevity,” Fitzsimons continued.

“It’s the best start to Perci,” she admitted. “If we can do it here we can do it anywhere.”

Indeed, the two aren’t the only ones confident in their abilities, as Perci Health closed its most recent seed funding round of £3.4m by Octopus Ventures with plans to grow their technological roadmap, and team, even more

Read more

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News
  • Life&Style

Categories

  • Entrepreneurship
  • Business

Related Topics

  • Health

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Mary Kay’s Pink Changing Lives® Program Turns Purpose Into Measurable Impact for Women Around the World

    Business Wire
  • The Debate: should Andy Burnham have made a woman his Chancellor?

    Opinion
    Rachel Reeves delivering a speech at a press event, wearing a navy blazer and standing in front of a backdrop with logos.
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • Who’s buying your business? Don’t wait until you’ve built it to decide – here’s why

    Partner
    Panelists Alison Stuckless, Howard Davies, Will Fraser-Allan, and Karim Palant at SCALE EXPO SUMMIT Day 2
  • What founders need to unlearn about fundraising and the one question no one thinks to ask investors

    Partner
    EIS and SEIS investors panel discussing fundraising insights at SCALE Summit, April 22, 2026
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook